Search PubMed⌕ Search

Biomedical subjects

M A Ferro

Publications and source records attributed to M A Ferro.

22 records · Page 2Linked to original sources

[Certificates of live birth: analysis of completion in the city of Ribeirão Preto, São Paulo, Brazil].

The study aims to identify the frequency with which certificates of live birth are filled out and to analyze the data they provide. To gather the data, the authors used a model birth certificate filled out by research assistants based on information obtained from the reports on mothers and newborns. This information was then compared to data contained in the official birth certificates available in the Information Technology Division of the Municipal Health Department. The sample consisted of 911 certificates of live birth from July 1996 in the ten maternity wards of the city of Ribeirão Preto. Data analysis showed that frequency of completion of birth certificates differs by hospital, involving both physicians and administrative personnel. The authors identified a high level of agreement in the data, i.e., over 90% in 13 of 18 variables compared in the birth certificates and in half of the hospitals investigated. The disagreement occurred especially with respect to data on the number of children per mother, number of prenatal visits, mother's schooling, and father's name.

Birth Certificates↗

Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies.

PSA and PSAP were examined in 198 prostatic biopsies and correlated with PSA and PSAP serum levels evaluated before biopsies. In every type of lesion there was no relation between PSA or PSAP serum levels and their expression in biopsy specimens. PSA and PSAP staining was similar in both cancer and benign hyperplasia and lower in dysplasia, atrophy and prostatitis; while serum levels were higher in adenocarcinomas than in other lesions. A significant difference of PSAP serum levels was noted in different Gleason's grading of neoplasia, found neither with PSA serum levels/nor with PSA and PSAP tissue staining.

Acid Phosphatase↗

[Fibrinolysis in acute CVA: the current status].

The use of thrombolytic therapy in acute ischemic stroke is still today a somewhat controversial subject. We come across authors who defend its undisputed use in adequately selected cases, others who are more sceptical and habitually place a question mark on this subject and a third group in expectation. Intra-arterial thrombolysis has very precise indications, its use in vertebrobasilar ischemic stroke remains inconclusive, eventually with a wider window. Five important randomised studies have taken place in recent years with thrombolysis administered intravenously. All three studies with Estreptoquinase--MAST-E, MAST-I and ASK--ended prematurely due to the high rates of mortality and intracranial haemorrhage observed in the group of patients treated with this drug. From the two main studies with rt-PA-ECASS and NINDS, the American trial showed somewhat higher results. The Guidelines from the American Heart Association for the use of rt-PA in ischemic stroke are presented. Fibrinolysis, when successful, only permits the restoration of blood flow in the area of ischemic suffering. This implies that, simultaneously, other therapeutic measures will have to be implemented.

Acute Disease↗